Citations

Citations to this article as recorded by  

• Patient-derived xenograft models: Current status, challenges, and innovations in cancer research
  Minqi Liu, Xiaoping Yang
  Genes & Diseases.2025; 12(5): 101520.     CrossRef
• Establishment and characterization of ovarian clear cell carcinoma patient-derived xenografts
  Joseph J. Caumanns, Shang Li, Gert J. Meersma, Evelien W. Duiker, Ate G. J. van der Zee, G. Bea A. Wisman, Steven de Jong
  Scientific Reports.2025;[Epub]     CrossRef
• The anti-tumor effects of AZD4547 on ovarian cancer cells: differential responses based on c-Met and FGF19/FGFR4 expression
  Yoo-Young Lee, Ji-Yoon Ryu, Young-Jae Cho, Ju-Yeon Choi, Jung-Joo Choi, Chel Hun Choi, Jason K. Sa, Jae Ryoung Hwang, Jeong-Won Lee
  Cancer Cell International.2024;[Epub]     CrossRef
• Creation and Validation of Patient-Derived Cancer Model Using Peritoneal and Pleural Effusion in Patients with Advanced Ovarian Cancer: An Early Experience
  Ruri Nishie, Tomohito Tanaka, Kensuke Hirosuna, Shunsuke Miyamoto, Hikaru Murakami, Hiromitsu Tsuchihashi, Akihiko Toji, Shoko Ueda, Natsuko Morita, Sousuke Hashida, Atsushi Daimon, Shinichi Terada, Hiroshi Maruoka, Hiromi Konishi, Yuhei Kogata, Kohei Tan
  Journal of Clinical Medicine.2024; 13(9): 2718.     CrossRef
• Anti-cancer effects of benzimidazole derivative BNZ-111 on paclitaxel-resistant ovarian cancer
  Byumseok Koh, Ji-Yoon Ryu, Joseph J. Noh, Jae Ryoung Hwang, Jung-Joo Choi, Young-Jae Cho, Jiyoon Jang, Jeong Hyeon Jo, Kwangho Lee, Jeong-Won Lee
  Gynecologic Oncology.2024; 188: 60.     CrossRef
• Recent advances in lung cancer organoid (tumoroid) research (Review)
  Qiang Zhang, Mingyang Zhang
  Experimental and Therapeutic Medicine.2024;[Epub]     CrossRef
• Patient‐derived xenograft model in colorectal cancer basic and translational research
  Xiaofeng Liu, Zechang Xin, Kun Wang
  Animal Models and Experimental Medicine.2023; 6(1): 26.     CrossRef
• Repurposing of triamterene as a histone deacetylase inhibitor to overcome cisplatin resistance in lung cancer treatment
  Kenneth K. W. To, Ka M. Cheung, William C. S. Cho
  Journal of Cancer Research and Clinical Oncology.2023; 149(10): 7217.     CrossRef
• Anti-cancer effect of fenbendazole-incorporated PLGA nanoparticles in ovarian cancer
  Chi-Son Chang, Ji-Yoon Ryu, June-Kuk Choi, Young-Jae Cho, Jung-Joo Choi, Jae Ryoung Hwang, Ju-Yeon Choi, Joseph J. Noh, Chan Mi Lee, Ji Eun Won, Hee Dong Han, Jeong-Won Lee
  Journal of Gynecologic Oncology.2023;[Epub]     CrossRef
• Molecular Biology of Pediatric and Adult Ovarian Germ Cell Tumors: A Review
  Mariana Tomazini Pinto, Gisele Eiras Martins, Ana Glenda Santarosa Vieira, Janaina Mello Soares Galvão, Cristiano de Pádua Souza, Carla Renata Pacheco Donato Macedo, Luiz Fernando Lopes
  Cancers.2023; 15(11): 2990.     CrossRef
• Generation, evolution, interfering factors, applications, and challenges of patient-derived xenograft models in immunodeficient mice
  Mingtang Zeng, Zijing Ruan, Jiaxi Tang, Maozhu Liu, Chengji Hu, Ping Fan, Xinhua Dai
  Cancer Cell International.2023;[Epub]     CrossRef
• Research Progress of PD-1/PD-L1 Inhibitors in Immunotherapy of Prostate Cancer
  佳慧 吴
  Advances in Clinical Medicine.2023; 13(06): 10496.     CrossRef
• Ulipristal acetate, a selective progesterone receptor modulator, induces cell death via inhibition of STAT3/CCL2 signaling pathway in uterine sarcoma
  Jae Ryoung Hwang, Young-Jae Cho, Ji-Yoon Ryu, Ju-Yeon Choi, Jung-Joo Choi, Jason K. Sa, Hyun-Soo Kim, Jeong-Won Lee
  Biomedicine & Pharmacotherapy.2023; 168: 115792.     CrossRef
• Establishment and characterization of a non-gestational choriocarcinoma patient-derived xenograft model
  Yukari Oda, Kaoru Niimi, Kosuke Yoshida, Satoshi Tamauchi, Akira Yokoi, Yuko Yasui, Yuki Nishiko, Mayu Shibata, Yusuke Shimizu, Masato Yoshihara, Yoshiki Ikeda, Nobuhisa Yoshikawa, Kimihiro Nishino, Eiko Yamamoto, Hiroaki Kajiyama
  BMC Cancer.2023;[Epub]     CrossRef
• Identification of Prognostic Markers of Gynecologic Cancers Utilizing Patient-Derived Xenograft Mouse Models
  Ha-Yeon Shin, Eun-ju Lee, Wookyeom Yang, Hyo Sun Kim, Dawn Chung, Hanbyoul Cho, Jae-Hoon Kim
  Cancers.2022; 14(3): 829.     CrossRef
• Three-Dimensional Modelling of Ovarian Cancer: From Cell Lines to Organoids for Discovery and Personalized Medicine
  Christine Yee, Kristie-Ann Dickson, Mohammed N. Muntasir, Yue Ma, Deborah J. Marsh
  Frontiers in Bioengineering and Biotechnology.2022;[Epub]     CrossRef
• Combination effect of poly (ADP-ribose) polymerase inhibitor and DNA demethylating agents for treatment of epithelial ovarian cancer
  Jung-In Shim, Ji-Yoon Ryu, Soo Young Jeong, Young-Jae Cho, Jung-Joo Choi, Jae Ryoung Hwang, Ju-Yeon Choi, Jason K. Sa, Jeong-Won Lee
  Gynecologic Oncology.2022; 165(2): 270.     CrossRef
• Endometrial Cancer Patient-Derived Xenograft Models: A Systematic Review
  Tomohito Tanaka, Ruri Nishie, Shoko Ueda, Shunsuke Miyamoto, Sousuke Hashida, Hiromi Konishi, Shinichi Terada, Yuhei Kogata, Hiroshi Sasaki, Satoshi Tsunetoh, Kohei Taniguchi, Kazumasa Komura, Masahide Ohmichi
  Journal of Clinical Medicine.2022; 11(9): 2606.     CrossRef
• Preclinical models of epithelial ovarian cancer: practical considerations and challenges for a meaningful application
  Alessandra Ciucci, Marianna Buttarelli, Anna Fagotti, Giovanni Scambia, Daniela Gallo
  Cellular and Molecular Life Sciences.2022;[Epub]     CrossRef
• Anticancer Activity of the Combination of Cabozantinib and Temozolomide in Uterine Sarcoma
  Joseph J. Noh, Young-Jae Cho, Ji-Yoon Ryu, Jung-Joo Choi, Jae Ryoung Hwang, Ju-Yeon Choi, Jeong-Won Lee
  Clinical Cancer Research.2022; 28(17): 3850.     CrossRef
• Harnessing preclinical models for the interrogation of ovarian cancer
  Tianyu Qin, Junpeng Fan, Funian Lu, Li Zhang, Chen Liu, Qiyue Xiong, Yang Zhao, Gang Chen, Chaoyang Sun
  Journal of Experimental & Clinical Cancer Research.2022;[Epub]     CrossRef
• The Development of a Three-Dimensional Platform for Patient-Derived Ovarian Cancer Tissue Models: A Systematic Literature Review
  Lusine Sevinyan, Priyanka Gupta, Eirini Velliou, Thumuluru Kavitha Madhuri
  Cancers.2022; 14(22): 5628.     CrossRef
• A Novel, Personalized Drug-Screening System for Platinum-Resistant Ovarian Cancer Patients: A Preliminary Clinical Report
  Yunke Huang, Jing Xu, Ke Li, Jing Wang, Yilin Dai, Yu Kang
  Cancer Management and Research.2021; Volume 13: 2849.     CrossRef
• Establishment and preclinical application of a patient-derived xenograft model for uterine cancer
  Soo Young Jeong, Young-Jae Cho, Ji-Yoon Ryu, Jung-Joo Choi, Jae-Ryoung Hwang, Binnari Kim, Yoo-Young Lee, Hyun-Soo Kim, Jeong-Won Lee
  Gynecologic Oncology.2021; 162(1): 173.     CrossRef
• Changes in Stem Cell Regulation and Epithelial Organisation during Carcinogenesis and Disease Progression in Gynaecological Malignancies
  Paula Cunnea, Christina Fotopoulou, Jennifer Ploski, Fabian Trillsch, Sven Mahner, Mirjana Kessler
  Cancers.2021; 13(13): 3349.     CrossRef
• Patient-Derived Xenograft Models in Cervical Cancer: A Systematic Review
  Tomohito Tanaka, Ruri Nishie, Shoko Ueda, Shunsuke Miyamoto, Sousuke Hashida, Hiromi Konishi, Shinichi Terada, Yuhei Kogata, Hiroshi Sasaki, Satoshi Tsunetoh, Kohei Taniguchi, Kazumasa Komura, Masahide Ohmichi
  International Journal of Molecular Sciences.2021; 22(17): 9369.     CrossRef
• Methodological aspects of creation of patient-derived tumor xenografts
  A S Goncharova, A N Shevchenko, I R Dashkova, A E Anisimov
  Kazan medical journal.2021; 102(5): 694.     CrossRef
• The safe and effective intraperitoneal chemotherapy with cathepsin B-specific doxorubicin prodrug nanoparticles in ovarian cancer with peritoneal carcinomatosis
  Jinseong Kim, Man Kyu Shim, Young-Jae Cho, Sangmin Jeon, Yujeong Moon, Jiwoong Choi, Jeongrae Kim, Jaewan Lee, Jeong-Won Lee, Kwangmeyung Kim
  Biomaterials.2021; 279: 121189.     CrossRef
• Modeling the Tumor Microenvironment of Ovarian Cancer: The Application of Self-Assembling Biomaterials
  Ana Karen Mendoza-Martinez, Daniela Loessner, Alvaro Mata, Helena S. Azevedo
  Cancers.2021; 13(22): 5745.     CrossRef
• Patient-Derived Xenografts of High-Grade Serous Ovarian Cancer Subtype as a Powerful Tool in Pre-Clinical Research
  Magdalena Cybula, Lin Wang, Luyao Wang, Ana Luiza Drumond-Bock, Katherine M. Moxley, Doris M. Benbrook, Camille Gunderson-Jackson, Maria J. Ruiz-Echevarria, Resham Bhattacharya, Priyabrata Mukherjee, Magdalena Bieniasz
  Cancers.2021; 13(24): 6288.     CrossRef
• Cytoplasmic expression of EGFR shRNA using a modified T7 autogene-based hybrid mRNA/DNA system induces long-term EGFR silencing and prolongs antitumor effects
  Sharmin Seraj, Young Jae Cho, Jeong-Won Lee, Hyung Jun Ahn
  Biochemical Pharmacology.2020; 171: 113735.     CrossRef
• The fidelity of cancer cells in PDX models: Characteristics, mechanism and clinical significance
  Jiahao Shi, Yongyun Li, Renbing Jia, Xianqun Fan
  International Journal of Cancer.2020; 146(8): 2078.     CrossRef
• KSP siRNA/paclitaxel-loaded PEGylated cationic liposomes for overcoming resistance to KSP inhibitors: Synergistic antitumor effects in drug-resistant ovarian cancer
  Jinju Lee, Young Jae Cho, Jeong-Won Lee, Hyung Jun Ahn
  Journal of Controlled Release.2020; 321: 184.     CrossRef
• A patient‐derived xenograft and a cell line derived from it form a useful preclinical model for small bowel adenocarcinoma
  Tomoki Yamano, Shuji Kubo, Naohiro Tomita
  Cancer Medicine.2020; 9(10): 3337.     CrossRef
• Preclinical assessment of the VEGFR inhibitor axitinib as a therapeutic agent for epithelial ovarian cancer
  E Sun Paik, Tae-Hyun Kim, Young Jae Cho, Jiyoon Ryu, Jung-Joo Choi, Yoo-Young Lee, Tae-Joong Kim, Chel-Hun Choi, Woo Young Kim, Jason K. Sa, Jin-Ku Lee, Byoung-Gie Kim, Duk-Soo Bae, Hee Dong Han, Hyung Jun Ahn, Jeong-Won Lee
  Scientific Reports.2020;[Epub]     CrossRef
• A Biobank of Colorectal Cancer Patient-Derived Xenografts
  Suad M. Abdirahman, Michael Christie, Adele Preaudet, Marie C. U. Burstroem, Dmitri Mouradov, Belinda Lee, Oliver M. Sieber, Tracy L. Putoczki
  Cancers.2020; 12(9): 2340.     CrossRef
• Epithelial/mesenchymal heterogeneity of high‐grade serous ovarian carcinoma samples correlates with miRNA let‐7 levels and predicts tumor growth and metastasis
  Evgeny Chirshev, Nozomi Hojo, Antonella Bertucci, Linda Sanderman, Anthony Nguyen, Hanmin Wang, Tise Suzuki, Emmanuel Brito, Shannalee R. Martinez, Christine Castañón, Saied Mirshahidi, Marcelo E. Vazquez, Pamela Wat, Kerby C. Oberg, Yevgeniya J. Ioffe, J
  Molecular Oncology.2020; 14(11): 2796.     CrossRef
• Human-Derived Model Systems in Gynecological Cancer Research
  Kadi Lõhmussaar, Matteo Boretto, Hans Clevers
  Trends in Cancer.2020; 6(12): 1031.     CrossRef
• Spontaneous and Induced Animal Models for Cancer Research
  Anca Onaciu, Raluca Munteanu, Vlad Cristian Munteanu, Diana Gulei, Lajos Raduly, Richard-Ionut Feder, Radu Pirlog, Atanas G. Atanasov, Schuyler S. Korban, Alexandru Irimie, Ioana Berindan-Neagoe
  Diagnostics.2020; 10(9): 660.     CrossRef
• Anti-Cancer Activity of As4O6 and its Efficacy in a Series of Patient-Derived Xenografts for Human Cervical Cancer
  Joseph J. Noh, Myeong-Seon Kim, Young-Jae Cho, Soo-Young Jeong, Yoo-Young Lee, Ji-Yoon Ryu, Jung-Joo Choi, Illju Bae, Zhaoyan Wu, Byoung-Gie Kim, Jae Ryoung Hwang, Jeong-Won Lee
  Pharmaceutics.2020; 12(10): 987.     CrossRef
• Patient-derived ovarian cancer explants: preserved viability and histopathological features in long-term agitation-based cultures
  Sofia Abreu, Fernanda Silva, Rita Mendes, Teresa F. Mendes, Marta Teixeira, Vítor E. Santo, Erwin R. Boghaert, Ana Félix, Catarina Brito
  Scientific Reports.2020;[Epub]     CrossRef
• Chloroquine reverses chemoresistance via upregulation of p21WAF1/CIP1 and autophagy inhibition in ovarian cancer
  Jae Ryoung Hwang, Woo Young Kim, Young-Jae Cho, Ji-Yoon Ryu, Jung-Joo Choi, Soo Young Jeong, Myeong-Sun Kim, Ji Hye Kim, E. Sun Paik, Yoo-Young Lee, Hee-Dong Han, Jeong-Won Lee
  Cell Death & Disease.2020;[Epub]     CrossRef
• Establishment of a Novel PDX Mouse Model and Evaluation of the Tumor Suppression Efficacy of Bortezomib Against Liposarcoma
  Eun Byeol Jo, Doopyo Hong, Young Sang Lee, Hyunjoo Lee, Jae Berm Park, Sung Joo Kim
  Translational Oncology.2019; 12(2): 269.     CrossRef
• Platinum Resistance in Ovarian Cancer: Role of DNA Repair
  Giovanna Damia, Massimo Broggini
  Cancers.2019; 11(1): 119.     CrossRef
• Establishment of patient‐derived xenograft model in ovarian cancer and its influence factors analysis
  Jianfa Wu, Yunxi Zheng, Qi Tian, Ming Yao, Xiaofang Yi
  Journal of Obstetrics and Gynaecology Research.2019; 45(10): 2062.     CrossRef
• Application of Highly Immunocompromised Mice for the Establishment of Patient-Derived Xenograft (PDX) Models
  Seiji Okada, Kulthida Vaeteewoottacharn, Ryusho Kariya
  Cells.2019; 8(8): 889.     CrossRef
• Current and Future Horizons of Patient-Derived Xenograft Models in Colorectal Cancer Translational Research
  Akira Inoue, Angela K. Deem, Scott Kopetz, Timothy P. Heffernan, Giulio F. Draetta, Alessandro Carugo
  Cancers.2019; 11(9): 1321.     CrossRef
• Pharmacogenomic analysis of patient-derived tumor cells in gynecologic cancers
  Jason K. Sa, Jae Ryoung Hwang, Young-Jae Cho, Ji-Yoon Ryu, Jung-Joo Choi, Soo Young Jeong, Jihye Kim, Myeong Seon Kim, E. Sun Paik, Yoo-Young Lee, Chel Hun Choi, Tae-Joong Kim, Byoung-Gie Kim, Duk-Soo Bae, Yeri Lee, Nam-Gu Her, Yong Jae Shin, Hee Jin Cho,
  Genome Biology.2019;[Epub]     CrossRef
• The latest animal models of ovarian cancer for novel drug discovery
  Elizabeth Magnotti, Wayne A. Marasco
  Expert Opinion on Drug Discovery.2018; 13(3): 249.     CrossRef
• Ovarian Cancers: Genetic Abnormalities, Tumor Heterogeneity and Progression, Clonal Evolution and Cancer Stem Cells
  Ugo Testa, Eleonora Petrucci, Luca Pasquini, Germana Castelli, Elvira Pelosi
  Medicines.2018; 5(1): 16.     CrossRef
• NIRF Optical/PET Dual-Modal Imaging of Hepatocellular Carcinoma Using Heptamethine Carbocyanine Dye
  Caiqin Zhang, Yong Zhao, Ningning Zhao, Dengxu Tan, He Zhang, Xue Chen, Hai Zhang, Jiaze An, Changhong Shi, Mengbin Li
  Contrast Media & Molecular Imaging.2018; 2018: 1.     CrossRef
• Comparison of Clinical Features and Outcomes in Epithelial Ovarian Cancer according to Tumorigenicity in Patient-Derived Xenograft Models
  Kyung Jin Eoh, Young Shin Chung, So Hyun Lee, Sun-Ae Park, Hee Jung Kim, Wookyeom Yang, In Ok Lee, Jung-Yun Lee, Hanbyoul Cho, Doo Byung Chay, Sunghoon Kim, Sang Wun Kim, Jae-Hoon Kim, Young Tae Kim, Eun Ji Nam
  Cancer Research and Treatment.2018; 50(3): 956.     CrossRef
• CD44-Targeting PLGA Nanoparticles Incorporating Paclitaxel and FAK siRNA Overcome Chemoresistance in Epithelial Ovarian Cancer
  Yeongseon Byeon, Jeong-Won Lee, Whan Soo Choi, Ji Eun Won, Ga Hee Kim, Min Gi Kim, Tae In Wi, Jae Myeong Lee, Tae Heung Kang, In Duk Jung, Young-Jae Cho, Hyung Jun Ahn, Byung Cheol Shin, Young Joo Lee, Anil K. Sood, Hee Dong Han, Yeong-Min Park
  Cancer Research.2018; 78(21): 6247.     CrossRef

Citations

Citations to this article as recorded by  

• Proton Pump Inhibitor Use and Obesity-Associated Cancer in the Women’s Health Initiative
  Tarah J. Ballinger, Zora Djuric, Sagar Sardesai, Kathleen M. Hovey, Chris A. Andrews, Theodore M. Brasky, Jian Ting Zhang, Thomas E Rohan, Nazmus Saquib, Aladdin H. Shadyab, Michael Simon, Jean Wactawski-Wende, Robert Wallace, Ikuko Kato
  Nutrition and Cancer.2023; 75(1): 265.     CrossRef
• Esomeprazole Alleviates Cisplatin Resistance by Inhibiting the AKT/mTOR Pathway in Ovarian Cancer Cells
  Jingya Duan, Zisen Zhang, Jinfeng Du, Jihua Zhang, Minmin Li, Canyu Li
  OncoTargets and Therapy.2023; Volume 16: 425.     CrossRef
• Proton pump inhibitors may enhance the risk of digestive diseases by regulating intestinal microbiota
  Liang Tian, Chongfei Huang, Wenkang Fu, Long Gao, Ningning Mi, Mingzhen Bai, Haidong Ma, Chao Zhang, Yawen Lu, Jinyu Zhao, Xianzhuo Zhang, Ningzu Jiang, Yanyan Lin, Ping Yue, Jinqiu Yuan, Wenbo Meng
  Frontiers in Pharmacology.2023;[Epub]     CrossRef
• Depression Events Associated with Proton-Pump Inhibitors in Postmarketing Drug Surveillance Data
  Tigran Makunts, Haroutyun Joulfayan, Kenneth Ta, Ruben Abagyan
  Pharmacoepidemiology.2023; 2(3): 272.     CrossRef
• Association between Proton Pump Inhibitor Use and the Risk of Female Cancers: A Nested Case-Control Study of 23 Million Individuals
  Nhi Thi Hong Nguyen, Chih-Wei Huang, Ching-Huan Wang, Ming-Chin Lin, Jason C. Hsu, Min-Huei Hsu, Usman Iqbal, Phung-Anh Nguyen, Hsuan-Chia Yang
  Cancers.2022; 14(24): 6083.     CrossRef
• Emerging insights on the role of V‐ATPase in human diseases: Therapeutic challenges and opportunities
  Cátia Santos‐Pereira, Lígia R. Rodrigues, Manuela Côrte‐Real
  Medicinal Research Reviews.2021; 41(4): 1927.     CrossRef
• Omeprazole improves chemosensitivity of gastric cancer cells by m6A demethylase FTO-mediated activation of mTORC1 and DDIT3 up-regulation
  Shuitu Feng, Guoqin Qiu, Lihong Yang, Lihua Feng, Xin Fan, Fang Ren, Kaida Huang, Yide Chen
  Bioscience Reports.2021;[Epub]     CrossRef
• Precise Cancer Anti-acid Therapy Monitoring Using pH-Sensitive MnO2@BSA Nanoparticles by Magnetic Resonance Imaging
  Rong A, Yuzhu Yao, Xiaolu Guo, Weiqi Jiang, Meng Jiang, Jie Yang, Yingbo Li, Olagbaju Oluwatosin Atinuke, Xuesong Hu, Yuanyuan Li, Xiance Wang, Lili Yang, Xiangliang Yang, Kai Wang, Jun Hu, Xilin Sun
  ACS Applied Materials & Interfaces.2021; 13(16): 18604.     CrossRef
• Rabeprazole has efficacy per se and reduces resistance to temozolomide in glioma via EMT inhibition
  Deepak Babu, Anwita Mudiraj, Neera Yadav, Chandrashekhar Y.B.V.K., Manas Panigrahi, Phanithi Prakash Babu
  Cellular Oncology.2021; 44(4): 889.     CrossRef
• How can proton pump inhibitors damage central and peripheral nervous systems?
  Tigran Makunts, Ruben Abagyan
  Neural Regeneration Research.2020; 15(11): 2041.     CrossRef
• Exploring the Therapeutic Potential of Membrane Transport Proteins: Focus on Cancer and Chemoresistance
  Shekoufeh Almasi, Yassine El Hiani
  Cancers.2020; 12(6): 1624.     CrossRef
• Serum- and glucocorticoid- inducible kinase 2, SGK2, is a novel autophagy regulator and modulates platinum drugs response in cancer cells
  Valentina Ranzuglia, Ilaria Lorenzon, Ilenia Pellarin, Maura Sonego, Alessandra Dall’Acqua, Sara D’Andrea, Sara Lovisa, Ilenia Segatto, Michela Coan, Jerry Polesel, Diego Serraino, Patrizia Sabatelli, Paola Spessotto, Barbara Belletti, Gustavo Baldassarre
  Oncogene.2020; 39(40): 6370.     CrossRef
• Elevated expression of the V‐ATPase D2 subunit triggers increased energy metabolite levels in KrasG12D‐driven cancer cells
  Jigang Yang, Feihu Guo, Leilei Yuan, Guangxin Lv, Jianhua Gong, Jing Chen
  Journal of Cellular Biochemistry.2019; 120(7): 11690.     CrossRef
• Pantoprazole attenuates tumorigenesis via inhibition of exosomal secretion in a rat model of hepatic precancerous lesion induced by diethylnitrosamine and 2‐acetamidofluorene
  Marwa Matboli, Asmaa Abd ElGwad, Amany H. Hasanin, Ahmed El‐Tawdi, Eman K. Habib, Rasha Ahmed` Elmansy, Doaa Ibrahim, Hanan Shehata, Fathy Tash
  Journal of Cellular Biochemistry.2019; 120(9): 14946.     CrossRef
• Vacuolar ATPase as a potential therapeutic target and mediator of treatment resistance in cancer
  Bradleigh Whitton, Haruko Okamoto, Graham Packham, Simon J. Crabb
  Cancer Medicine.2018; 7(8): 3800.     CrossRef
• Protein Pump Inhibitors Esomeprazole and Pantoprazole Increase the Chemosensitivity of CML cells against Imatinib
  Merve Ergül, Mustafa Ergül
  Cumhuriyet Medical Journal.2018;[Epub]     CrossRef
• Value of pH regulators in the diagnosis, prognosis and treatment of cancer
  Sara Granja, Diana Tavares-Valente, Odília Queirós, Fátima Baltazar
  Seminars in Cancer Biology.2017; 43: 17.     CrossRef
• Triple-edged therapy targeting intracellular alkalosis and extracellular acidosis in cancer
  Tomas Koltai
  Seminars in Cancer Biology.2017; 43: 139.     CrossRef